American Vietnamese Biotech Incorporation reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported revenue was VND 58,951.81 million compared to VND 84,819.35 million a year ago. Net income was VND 1,762.52 million compared to VND 40,002.9 million a year ago.
For the full year, revenue was VND 281,818.06 million compared to VND 223,842.79 million a year ago. Net income was VND 53,931.41 million compared to VND 82,239.75 million a year ago. Basic earnings per share from continuing operations was VND 502 compared to VND 977 a year ago. Diluted earnings per share from continuing operations was VND 502 compared to VND 977 a year ago.